Triazole Resistance in Aspergillus Species: An Emerging Problem
Related Experiment Video
Updated: Mar 7, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Rocio Garcia-Rubio1, Manuel Cuenca-Estrella1, Emilia Mellado2
1Mycology Department, Centro Nacional de Microbiologia, Instituto de Salud Carlos III (ISCIII), Carretera Majadahonda-Pozuelo Km2, Majadahonda, 28220, Madrid, Spain.
Abstract:
Aspergillus species are ubiquitous fungal saprophytes found in diverse ecological niches worldwide. Among them, Aspergillus fumigatus is the most prevalent and is largely responsible for the increased incidence of invasive aspergillosis with high mortality rates in some immunocompromised hosts. Azoles are the first-line drugs in treating diseases caused by Aspergillus spp. However, increasing reports in A. fumigatus azole resistance, both in the clinical setting and in the environment, are threatening the effectiveness of clinical and agricultural azole drugs. The azole target is the 14-α sterol demethylase encoded by cyp51A gene and the main mechanisms of resistance involve the integration of tandem repeats in its promoter and/or single point mutations in this gene. In A. fumigatus, azole resistance can emerge in two different scenarios: a medical route in which azole resistance is generated during long periods of azole treatment in the clinical setting and a route of resistance derived from environmental origin due to extended use of demethylation inhibitors in agriculture. The understanding of A. fumigatus azole resistance development and its evolution is needed in order to prevent or minimize its impact. In this article, we review the current situation of azole resistance epidemiology and the predominant molecular mechanisms described based on the resistance acquisition routes. In addition, the clinical implications of A. fumigatus azole resistance and future research are discussed.
Insights
Azole resistance in Aspergillus fumigatus, a major cause of invasive aspergillosis, is increasing due to clinical and agricultural azole use. Understanding resistance mechanisms is crucial for effective treatment and prevention.
Area of Science:
- Medical Mycology
- Antifungal Resistance
- Fungal Pathogenesis
Background:
- Aspergillus fumigatus is a prevalent fungus causing invasive aspergillosis in immunocompromised individuals.
- Azole antifungals are first-line treatments, but resistance is a growing global concern.
- Resistance threatens both clinical antifungal therapy and agricultural applications of azoles.
Purpose of the Study:
- To review the epidemiology of azole resistance in Aspergillus fumigatus.
- To elucidate the predominant molecular mechanisms driving azole resistance.
- To discuss the clinical implications and future research directions for azole resistance.
Main Methods:
- Literature review of studies on Aspergillus fumigatus azole resistance.
- Analysis of epidemiological data on resistance prevalence.
- Examination of molecular mechanisms including cyp51A gene mutations and promoter alterations.
Main Results:
- Azole resistance in A. fumigatus arises from both medical (treatment-driven) and environmental (agricultural use-driven) routes.
- Key resistance mechanisms involve alterations in the cyp51A gene, encoding the azole target 14-α sterol demethylase.
- Tandem repeat insertions in the promoter and point mutations within the cyp51A gene are predominant.
Conclusions:
- Azole resistance in A. fumigatus poses a significant threat to public health and agriculture.
- Understanding the distinct evolutionary pathways of resistance is vital for intervention strategies.
- Further research is needed to combat the rising challenge of azole-resistant Aspergillus fumigatus infections.
More Related Videos
09:21Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.
Published on: February 15, 2019
08:45Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Related Concept Videos
Fungal Phylum Ascomycota
Treatment Resistant Cancers
Fungal Group Zygomycota